BioSpace News Archive

BioMidwest

Biodesix to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Biodesix, Inc. announced Scott Hutton, Chief Executive Officer of Biodesix, will present in a fireside chat at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference being held virtually February 15-17, 2022.

February 9, 2022

·

3 min read

BioMidwest

University Hospital Halle (Saale) Selects ViewRay’s MRIdian® System to Broaden Advanced Radiation Therapy Treatment Services

MRIdian will be the First MRI-guided Radiation Therapy System at Krukenberg Cancer Center.

February 9, 2022

·

6 min read

Biotech Beach

ChromaDex Announces Issuance of New U.S. Continuation Patent, Expanding Intellectual Property Portfolio for Nicotinamide Riboside

ChromaDex Corp. (NASDAQ:CDXC) today announced that it was granted a continuation patent, adding to its global patent portfolio surrounding nicotinamide riboside.

February 9, 2022

·

3 min read

Business

MagTrack Technology Opens Doors for Independent Operation of Smartphones, Computers, Other Devices for Wheelchair Users

Brooks Rehabilitation is pleased to announce the MagTrack study, a collaborative research endeavor between Brooks and the Georgia Tech School of Electrical and Computer Engineering , has been successfully completed.

February 9, 2022

·

9 min read

Genetown

TCR² Therapeutics to Present at the SVB Leerink Global Healthcare Conference

TCR 2 Therapeutics Inc. today announced that management will participate in a fireside chat at the 11th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 16 at 1:40PM E.T. using a virtual platform.

February 9, 2022

·

1 min read

Business

Foundation Medicine Announces Global Collaboration With Lilly to Develop FoundationOne®CDx and FoundationOne®Liquid CDx as Companion Diagnostics for RETEVMO® and Loxo Oncology at Lilly’s Pipeline Programs

Foundation Medicine, Inc. today announced a collaboration with Eli Lilly and Company (Lilly) for the development of Foundation Medicine’s tissue- and blood-based assays as companion diagnostics for RETEVMO.

February 9, 2022

·

5 min read

Genetown

Cogent Biosciences to Present at 11th Annual SVB Leerink Global Healthcare Conference

Cogent Biosciences, Inc. today announced Andrew Robbins, Chief Executive Officer and President, will participate in a fireside chat during the 11th Annual SVB Leerink Global Healthcare Conference, taking place virtually February 14 – 18, 2022.

February 9, 2022

·

1 min read

Business

ONL Therapeutics Appoints Sushanta Mallick as Chief Development Officer

ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal disease, announced the appointment of Sushanta Mallick, PhD, MBA, to the newly created position of Chief Development Officer.

February 9, 2022

·

4 min read

Business

Anavex Life Sciences Provides Business Update and Reports Fiscal 2022 First Quarter Financial Results

Anavex Life Sciences Corp. reported financial results for its fiscal quarter ended December 31, 2021.

February 9, 2022

·

8 min read

Business

PolyPid Provides Corporate Update and Reports Fourth Quarter and Full-Year 2021 Financial Results

PolyPid Ltd., a Phase 3 biopharmaceutical company focused on developing targeted, locally administered, and prolonged-release therapeutics using its proprietary PLEX technology, provided a corporate update and reported financial results for the three months and full-year ended December 31, 2021.

February 9, 2022

·

11 min read